FDA Grants Full Approval To Leqembi, The First Alzheimer's Drug Shown To Slow Cognitive Decline
(CTN NEWS) - The Food and Drug Administration (FDA) has endorsed the intravenous (IV) drug Leqembi for patients with mild dementia and early Alzheimer's
Source: chiangraitimes.com